Shedding new light on the mechanism underlying stem cell therapy for the heart

Molecular Therapy

Volumn 19, Issue 7, 2011, Pages 1186-1188

  Mummery, Christine ^a   Goumans, Marie Jose ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; STEM CELL FACTOR;

CELL DIFFERENTIATION; CELL LINEAGE; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR MECHANICS; NONHUMAN; NOTE;

EID: 79959926623     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.117     Document Type: Note

References (11)

1. Hsieh, PC, Segers, VF, Davis, ME, MacGillivray, C, Gannon, J, Molkentin, JD et al. (2007). Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 13: 970-974. (Pubitemid 47222045)
2. Bergmann, O, Bhardwaj, RD, Bernard, S, Zdunek, S, Barnabé-Heider, F, Walsh, S et al. (2009). Evidence for cardiomyocyte renewal in humans. Science 324: 98-102.
3. Passier, R, van Laake, LW and Mummery, CL (2008). Stem-cell-based therapy and lessons from the heart. Nature 453: 322-329. (Pubitemid 351693138)
4. Smits, AM, Ramkisoensing, AA, Atsma, DE and Goumans, MJ (2010). Young at heart. An update on cardiac regeneration. Minerva Med 101: 255-270.
5. Loffredo, FS, Steinhauser, ML, Gannon, J and Lee, RT (2011). Bone marrow?derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8: 389-398.
6. Abdel-Latif, A, Bolli, R, Tleyjeh, IM, Montori, VM, Perin, EC, Hornung, CA et al. (2007). Adult bone marrow?derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167: 989-997. (Pubitemid 46835786)
7. Hirsch, A, Nijveldt, R, van der Vleuten, PA, Tijssen, JG, van der Giessen, WJ, Tio, RA et al. (2010). Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J; e-pub ahead of print 10 December 2010.
8. Herbots, L, D'hooge, J, Eroglu, E, Thijs, D, Ganame, J, Claus, P et al. (2009). Improved regional function after autologous bone marrow?derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. Eur Heart J 30: 662-670.
9. Assmus, B, Rolf, A, Erbs, S, Elsässer, A, Haberbosch, W, Hambrecht, R et al. (2010). Clinical outcome 2 years after intracoronary administration of bone marrow?derived progenitor cells in acute myocardial infarction. Circ Heart Fail 3: 89-96.
10. Hansson, EM, Lindsay, ME and Chien, KR (2009). Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 5: 364-377.
11. Mummery, CL, Davis, RP and Krieger, JE (2010). Challenges in using stem cells for cardiac repair. Sci Transl Med 2: 27ps17.